| 1 day | -1.13% |
| 3 years | 4.81 |  | 31.5 |
| 5 years | 4.81 | | 64.5 |
| 10 years | 4.81 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Evan Loh
CEO | Chief Executive Officer | 67 | 20/05/2025 |
| Chief Tech/Sci/R&D Officer | - | 31/12/2019 | |
Jonathan Neely
IRC | Investor Relations Contact | - | 31/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Evan Loh
BRD | Director/Board Member | 67 | 20/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 21/05/25 | Issuer sale | Chief Executive Officer | 452,016 | 4.4953% | ||
| 21/05/25 | Issuer sale | Chief Financial Officer | 82,491 | 0.8204% | ||
| 21/05/25 | Issuer sale | Director | 12,624 | 0.1255% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.13% | -.--% | - | - | 97.22M | |
| +0.83% | +3.19% | +41.49% | +94.83% | 1,051B | |
| +1.93% | +2.11% | +37.08% | +67.40% | 630B | |
| +1.49% | +5.19% | +19.94% | +85.13% | 489B | |
| +2.26% | +0.90% | +69.32% | +40.73% | 359B | |
| +1.45% | +3.50% | +23.29% | +40.84% | 344B | |
| +1.17% | +2.37% | +13.47% | +32.81% | 272B | |
| +0.89% | +1.08% | -6.13% | +9.63% | 246B | |
| +1.82% | +2.94% | +42.99% | +46.29% | 224B | |
| +2.77% | +4.44% | +29.01% | +96.43% | 187B | |
| Average | +1.35% | +2.86% | +30.05% | +57.12% | 422.63B | |
| Weighted average by Cap. | +1.47% | +2.93% | +33.36% | +66.30% |
Employees
128
Sector
Pharmaceuticals
